VEGFA has been reported to promote tumor metastasis, and TAN were found to counteract anti-VEGF therapy in metastatic colorectal cancer (Stockmann et al, 2008; Kim et al, 2017; Schiffmann et al, 2019). This evidence concerns the gene VEGFA and neoplasm.